Susquehanna International Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-92,700
Closed -$32K 10992
2018
Q2
$32K Buy
92,700
+42,500
+85% +$34.9K ﹤0.01% 9366
2018
Q1
$75K Sell
50,200
-28,600
-36% -$49.9K ﹤0.01% 8822
2017
Q4
$112K Buy
78,800
+17,500
+29% +$28.7K ﹤0.01% 8645
2017
Q3
$140K Buy
61,300
+32,500
+113% +$43.5K ﹤0.01% 8235
2017
Q2
$39K Sell
28,800
-22,100
-43% -$31.9K ﹤0.01% 8939
2017
Q1
$109K Sell
50,900
-78,500
-61% -$295K ﹤0.01% 8353
2016
Q4
$571K Sell
129,400
-66,100
-34% -$314K ﹤0.01% 6708
2016
Q3
$948K Buy
195,500
+107,100
+121% +$488K ﹤0.01% 4913
2016
Q2
$292K Sell
88,400
-231,600
-72% -$874K ﹤0.01% 7008
2016
Q1
$1.14M Buy
+320,000
New +$1.65M ﹤0.01% 4829

Other funds holding ARLZ

Susquehanna International Group's ARLZ Position: Q3 2018 in Review

Susquehanna International Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 39,211 shares — an estimated $14K sold.

Susquehanna International Group first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.12M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Susquehanna International Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Susquehanna International Group sold 39,211 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $14K.
  • Susquehanna International Group first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Susquehanna International Group's Aralez Pharmaceuticals Inc. position peaked at $1.12M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.